Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$24.57 - $28.47 $464,422 - $538,139
-18,902 Reduced 51.36%
17,899 $453,000
Q1 2024

May 14, 2024

SELL
$21.95 - $26.42 $475,480 - $572,310
-21,662 Reduced 37.05%
36,801 $934,000
Q4 2023

Feb 09, 2024

BUY
$18.47 - $23.3 $144,269 - $181,996
7,811 Added 15.42%
58,463 $1.32 Million
Q3 2023

Nov 13, 2023

BUY
$16.98 - $26.1 $860,070 - $1.32 Million
50,652 New
50,652 $943,000
Q4 2022

Feb 13, 2023

BUY
$23.85 - $31.91 $273,917 - $366,486
11,485 Added 75.6%
26,677 $789,000
Q3 2022

Nov 14, 2022

SELL
$21.74 - $24.68 $129,700 - $147,240
-5,966 Reduced 28.2%
15,192 $362,000
Q2 2022

Aug 11, 2022

BUY
$20.4 - $25.53 $113,179 - $141,640
5,548 Added 35.54%
21,158 $472,000
Q1 2022

May 13, 2022

BUY
$24.7 - $36.54 $385,567 - $570,389
15,610 New
15,610 $392,000
Q3 2021

Nov 12, 2021

SELL
$38.75 - $44.47 $193,982 - $222,616
-5,006 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$39.42 - $48.08 $197,336 - $240,688
5,006 New
5,006 $217,000
Q1 2020

May 08, 2020

SELL
$22.38 - $54.06 $230,133 - $555,898
-10,283 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$51.85 - $73.36 $231,406 - $327,405
4,463 Added 76.68%
10,283 $533,000
Q3 2019

Nov 08, 2019

BUY
$40.05 - $57.47 $233,090 - $334,475
5,820 New
5,820 $319,000
Q2 2019

Aug 09, 2019

SELL
$30.3 - $41.14 $358,146 - $486,274
-11,820 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$29.37 - $40.49 $347,153 - $478,591
11,820 New
11,820 $357,000
Q4 2018

Feb 13, 2019

SELL
$30.16 - $43.0 $162,954 - $232,329
-5,403 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$32.83 - $42.51 $177,380 - $229,681
5,403 New
5,403 $228,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $240M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.